Valuation: Avinger, Inc.

Market Cap 2.71M 2.38M 2.19M 2.04M 3.85M 258M 3.93M 26.32M 10.2M 126M 10.17M 9.94M 440M P/E 2022
-0.25x
P/E 2023 -0.19x
Enterprise Value 12.83M 11.27M 10.38M 9.66M 18.24M 1.22B 18.61M 125M 48.34M 599M 48.17M 47.11M 2.08B EV / Sales 2022
1.19x
EV / Sales 2023 1.78x
Free-Float
88.44%
Yield 2022 *
-
Yield 2023 -
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 2024-08-04
Change 5-day change 1-year change 3-year change Capi.($)
-15.90%+1,100.00% - - 1.52M
+2.62%+1.33%-18.68%-24.73% 12.22B
-0.15%+11.17%+97.86%+20.30% 5.4B
+2.60%+6.15%+63.97%+105.36% 1.22B
+4.51%+1.69%-35.33%-64.73% 1.17B
+3.72%-5.78%-38.66%-49.11% 1.06B
+4.37%-5.16%-43.07% - 866M
-0.29%-3.11%+171.20%+165.95% 656M
-2.77%+13.38% - - 379M
-1.96%+16.96%-53.90%+241.33% 287M
Average -0.33%+6.64%+17.92%+56.34% 2.58B
Weighted average by Cap. +1.96%+4.43%+15.56%-0.60%

Financials

2022 2023
Net sales 8.27M 7.27M 6.7M 6.23M 11.76M 788M 12M 80.43M 31.17M 386M 31.07M 30.38M 1.34B 7.65M 6.73M 6.19M 5.76M 10.88M 729M 11.1M 74.4M 28.83M 357M 28.73M 28.1M 1.24B
Net income -17.62M -15.49M -14.26M -13.27M -25.06M -1.68B -25.57M -171M -66.41M -823M -66.17M -64.72M -2.86B -18.32M -16.1M -14.83M -13.8M -26.05M -1.74B -26.58M -178M -69.03M -855M -68.79M -67.28M -2.98B
Net Debt 1.76M 1.54M 1.42M 1.32M 2.5M 167M 2.55M 17.07M 6.62M 81.97M 6.59M 6.45M 285M 10.12M 8.89M 8.19M 7.62M 14.39M 964M 14.68M 98.39M 38.13M 472M 38M 37.17M 1.64B
Logo Avinger, Inc.
Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.
Employees
-